Effectiveness and safety of imeglimin in routine clinical practice among Indian patients with type 2 diabetes mellitus: a prospective, non-interventional, real-world observational study (INDI-TIMES 2.0)
- DOI
- 10.3389/fendo.2026.1973270
- Published
- 2026-10-12
- Container
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fendo.2026.1973270,
title = {Effectiveness and safety of imeglimin in routine clinical practice among Indian patients with type 2 diabetes mellitus: a prospective, non-interventional, real-world observational study (INDI-TIMES 2.0)},
author = {Debmalya Sanyal and Anuj Maheshwari and Subrata Chakrabarti and Manoj Chawla and Mangesh Tiwaskar and Soujanya Kunapa Reddy and S Sridhar and Arthur Joseph Ashirvatham and Rituraj Benode Deb and Gayathry V M},
year = {2026},
journal = {Frontiers in Endocrinology},
doi = {10.3389/fendo.2026.1973270},
url = {https://doi.org/10.3389/fendo.2026.1973270}
}RIS
TY - JOUR TI - Effectiveness and safety of imeglimin in routine clinical practice among Indian patients with type 2 diabetes mellitus: a prospective, non-interventional, real-world observational study (INDI-TIMES 2.0) AU - Debmalya Sanyal AU - Anuj Maheshwari AU - Subrata Chakrabarti AU - Manoj Chawla AU - Mangesh Tiwaskar AU - Soujanya Kunapa Reddy AU - S Sridhar AU - Arthur Joseph Ashirvatham AU - Rituraj Benode Deb AU - Gayathry V M PY - 2026 JO - Frontiers in Endocrinology DO - 10.3389/fendo.2026.1973270 UR - https://doi.org/10.3389/fendo.2026.1973270 ER -
APA
Sanyal, D., Maheshwari, A., Chakrabarti, S., Chawla, M., Tiwaskar, M., Reddy, S. K., Sridhar, S., Ashirvatham, A. J., Deb, R. B., & M, G. V. (2026). Effectiveness and safety of imeglimin in routine clinical practice among Indian patients with type 2 diabetes mellitus: a prospective, non-interventional, real-world observational study (INDI-TIMES 2.0). Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1973270
Source records
- crossref · retrieved 2026-11-10T21:14:40.777Z